Zekraoui O. et al., 2025: Costs of resolving a ureteral or kidney stone episode worldwide: a systematic review.

Othmane Zekraoui, Ibrahim Moussa, Nick Lee, David-Dan Nguyen, Abbas Guennoun, David Bouhadana, Liam Murad, Nicolas Siron, Kelven Chen, Naeem Bhojani
Int Urol Nephrol. 2025 Sep 15. doi: 10.1007/s11255-025-04784-9

Abstract

Purpose: This systematic review compares the costs of common urolithiasis surgical options worldwide, identifies sources of heterogeneity in cost reporting, and propose recommendations for standardizing economic evaluations with the aim of reducing urolithiasis' financial burden globally.

Methods: We systematically searched Medline, EMBASE and Web of Science for studies published between 2014 and 2024. Included studies involved adult patients treated for a urolithiasis, described components of cost calculations, and provided a monetary value. Data was summarized qualitatively, and costs were first inflated, then converted to 2024 USD for comparability.

Results: After identifying 2,461 references, 38 studies from 13 countries met the inclusion criteria. Variations in the definition of stone-free status were noted, with 17 studies not specifying it at all. While most studies accounted for procedural and hospital stay costs, the rest of the cost calculation components varied significantly. The costs of managing an episode with URS ranged from 249.12 to 48,937 USD, as for ESWL, the costs ranged from 177.48 to 10,184.64 USD. The costs of managing an episode using PCNL presented the largest disparity, ranging from 164.89 to 101,510.23 USD. Finally, studies assessing the management using MET reported costs from 293.89 to 17,982.19 USD.

Conclusion: Our review highlights substantial variability in urolithiasis treatment costs worldwide. Standardizing cost calculation methods and clinical success definitions is critical for guiding cost-effective decision-making and supporting evidence-based strategies to optimize resource allocation and reduce urolithiasis' financial burden globally.

Comment Peter Alken

Publishers should develop a template forcing authors submitting manuscripts on heath care costs to adhere to strict principles concerning data collection and data comparison. Otherwise reading the divergent details and results is just a waste of time.

Peter Alken